Lead sponsor
OPKO Health, Inc.
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
0
Active
581
Total enrollment
54
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
2
Trials by status
Completed
2
Terminated
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 DiabetesBMI 23-45Ph 2Completed420
Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes SubjectsBMI 27-45Ph 2Completed113